White tea alleviates non-alcoholic fatty liver disease by regulating energy expenditure and lipid metabolism

Gene. 2022 Jul 30:833:146553. doi: 10.1016/j.gene.2022.146553. Epub 2022 May 13.

Abstract

Non-alcoholic fatty liver disease (NAFLD) is one of the leading causes of liver disease, which lacks effective treatments. Abnormal lipid metabolism and inflammation are the most prominent pathological manifestations of NAFLD. Recently, it has been reported that white tea extract (WTE) can regulate lipid metabolism in human adipocytes and liver cancer cells in vitro. However, its beneficial effects on NAFLD and the underlying mechanisms remain largely unknown. Here, we showed that WTE alleviated obesity, lipid accumulation, hepatic steatosis, and liver injury in a mouse model of NAFLD. Mechanistically, we demonstrated that WTE exerted the anti-NAFLD effect by decreasing the expression of genes involved in lipid transport and synthesis processes while activating genes associated with energy expenditure. In addition, a comparison of the transcriptional responses of WTE with that of green tea extract (GTE) revealed that WTE can not only regulate lipid metabolism and stress response like GTE but also regulate antioxidant and inflammatory pathways more effectively. Taken together, our findings demonstrate that WTE inhibits the progression of NAFLD in a mouse model and indicate that WTE can be a potential dietary intervention for NAFLD.

Keywords: Energy expenditure; Lipid metabolism; NAFLD; Transcriptomics; White tea.

MeSH terms

  • Animals
  • Antioxidants / pharmacology
  • Diet, High-Fat
  • Disease Models, Animal
  • Energy Metabolism
  • Lipid Metabolism
  • Lipids
  • Liver / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Non-alcoholic Fatty Liver Disease* / drug therapy
  • Non-alcoholic Fatty Liver Disease* / metabolism
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use
  • Tea / metabolism

Substances

  • Antioxidants
  • Lipids
  • Plant Extracts
  • Tea